
Unveiling the Future of Pharma: Why Major U.S. Drug Companies Are Looking East
U.S. pharmaceutical companies are increasingly collaborating with Chinese biotech firms, marking a significant shift in the industry. 2024 witnessed a notable rise in major upfront deals involving Chinese entities, with a dramatic increase from five years ago. Chinese firms excel in drug